The prognostic value of tumour-stroma ratio in triple-negative breast cancer

European Journal of Surgical Oncology

Volumn 38, Issue 4, 2012, Pages 307-313

  Moorman, A M ^a,e   Vink, R ^b,f   Heijmans, H J ^a   Van Der Palen, J ^c,d   Kouwenhoven, E A ^a,e  

^a Hospital Group Twente   (Netherlands)

^b Pathology East Netherlands ^*  (Netherlands)

^c UNIVERSITY OF TWENTE   (Netherlands)

^d MEDISCH SPECTRUM TWENTE   (Netherlands)

^e NONE   (Netherlands)

^f NONE   (Netherlands)

Author keywords

Prognostic value; Survival; Triple negative breast cancer; Tumour stroma

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE FREE INTERVAL; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; STRATIFICATION; STROMA; TRIPLE NEGATIVE BREAST CANCER;

EID: 84857924444     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.01.002     Document Type: Article

References (42)

1. cancer.org. Available at: http://www.cancer.org/acs/groups/content/ @epidemiologysurveilance/documents/document/acspc-027766.pdf.
2. B.K. Edwards, M.L. Brown, and P.A. Wingo Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment J Natl Cancer Inst 97 19 2005 Oct 5 1407 1427 (Pubitemid 41520077)
3. K.R. Bauer, M. Brown, R.D. Cress, C.A. Parise, and V. Caggiano Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry Cancer 109 9 2007 May 1 1721 1728 (Pubitemid 46668532)
4. R. Dent, M. Trudeau, and K.I. Pritchard Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 15 Pt 1 2007 Aug 1 4429 4434 (Pubitemid 47219710)
5. B.G. Haffty, Q. Yang, and M. Reiss Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol 24 36 2006 Dec 20 5652 5657 (Pubitemid 46631305)
6. E.A. Rakha, M.E. El-Sayed, A.R. Green, A.H. Lee, J.F. Robertson, and I.O. Ellis Prognostic markers in triple-negative breast cancer Cancer 109 1 2007 Jan 1 25 32 (Pubitemid 46120191)
7. E.A. Rakha, J.S. Reis-Filho, and I.O. Ellis Basal-like breast cancer: a critical review J Clin Oncol 26 15 2008 May 20 2568 2581
8. C. Sotiriou, and L. Pusztai Gene-expression signatures in breast cancer N Engl J Med 360 8 2009 Feb 19 790 800
9. M. Tischkowitz, J.S. Brunet, and L.R. Begin Use of immunohistochemical markers can refine prognosis in triple negative breast cancer BMC Cancer 7 2007 Jul 24 134
10. B.P. Schneider, E.P. Winer, and W.D. Foulkes Triple-negative breast cancer: risk factors to potential targets Clin Cancer Res 14 24 2008 Dec 15 8010 8018
11. J.S. Reis-Filho, and A.N. Tutt Triple negative tumours: a critical review Histopathology 52 1 2008 Jan 108 118 (Pubitemid 350265179)
12. J.S. Reis-Filho, and S.R. Lakhani Breast cancer special types: why bother? J Pathol 216 4 2008 Dec 394 398
13. A.A. Thike, J. Iqbal, and P.Y. Cheok Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers Am J Surg Pathol 34 7 2010 Jul 956 964
14. S. Badve Does tumor size trump biology? Clin Breast Cancer 10 2 2010 Apr 111 112
15. W.D. Foulkes, I.E. Smith, and J.S. Reis-Filho Triple-negative breast cancer N Engl J Med 363 20 2010 Nov 11 1938 1948
16. L.G. Fulford, J.S. Reis-Filho, and K. Ryder Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival Breast Cancer Res 9 1 2007 R4
17. M.J. Bissell, and D. Radisky Putting tumours in context Nat Rev Cancer 1 1 2001 Oct 46 54 (Pubitemid 33741880)
18. H.Y. Chang, D.S. Nuyten, and J.B. Sneddon Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival Proc Natl Acad Sci USA 102 10 2005 Mar 8 3738 3743 (Pubitemid 40354681)
19. T.D. Tlsty, and P.W. Hein Know thy neighbor: stromal cells can contribute oncogenic signals Curr Opin Genet Dev 11 1 2001 Feb 54 59 (Pubitemid 32119278)
20. O. De Wever, and M. Mareel Role of tissue stroma in cancer cell invasion J Pathol 200 4 2003 Jul 429 447 (Pubitemid 36818244)
21. J.B. Kim, R. Stein, and M.J. O'Hare Tumour-stromal interactions in breast cancer: the role of stroma in tumourigenesis Tumour Biol 26 4 2005 Jul-Aug 173 185 (Pubitemid 41379743)
22. J.M. Seoane, J. Cameselle-Teijeiro, and M.A. Romero Poorly differentiated oxyphilic (Hurthle cell) carcinoma arising in lingual thyroid: a case report and review of the literature Endocr Pathol Winter 13 4 2002 353 360 (Pubitemid 36237989)
23. W.E. Mesker, J.M. Junggeburt, and K. Szuhai The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage Cell Oncol 29 5 2007 387 398 (Pubitemid 47255977)
24. W.E. Mesker, G.J. Liefers, and J.M. Junggeburt Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients Cell Oncol 31 3 2009 169 178
25. E.F. Courrech Staal, M.W. Wouters, and J.W. van Sandick The stromal part of adenocarcinomas of the oesophagus: does it conceal targets for therapy? Eur J Cancer 46 4 2010 Mar 720 728
26. E.M. de Kruijf, J.G. van Nes, and C.J. van de Velde Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients Breast Cancer Res Treat 125 3 2011 Feb 687 696
27. M.H. Galea, R.W. Blamey, C.E. Elston, and I.O. Ellis The Nottingham Prognostic Index in primary breast cancer Breast Cancer Res Treat 22 3 1992 207 219
28. A. Goldhirsch, A.S. Coates, and R.D. Gelber First-select the target: better choice of adjuvant treatments for breast cancer patients Ann Oncol 17 12 2006 Dec 1772 1776 (Pubitemid 44884051)
29. Ajuvant! Online Available at: www.adjuvantonline.com.
30. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 9472 2005 May 14-20 1687 1717
31. S. Aebi, S. Gelber, and M. Castiglione-Gertsch Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet 355 9218 2000 May 27 1869 1874 (Pubitemid 30311879)
32. J. O'Shaughnessy, C. Osborne, and J.E. Pippen Iniparib plus chemotherapy in metastatic triple-negative breast cancer N Engl J Med 364 3 2011 Jan 20 205 214
33. M.H. Barcellos-Hoff The potential influence of radiation-induced microenvironments in neoplastic progression J Mammary Gland Biol Neoplasia 3 2 1998 Apr 165 175 (Pubitemid 128513228)
34. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 3 1996 Aug 9 353 364 (Pubitemid 26272076)
35. M. Hu, and K. Polyak Microenvironmental regulation of cancer development Curr Opin Genet Dev 18 1 2008 Feb 27 34 (Pubitemid 351694443)
36. M.E. Lukashev, and Z. Werb ECM signalling: orchestrating cell behaviour and misbehaviour Trends Cell Biol 8 11 1998 Nov 437 441 (Pubitemid 28529716)
37. L. Ronnov-Jessen, O.W. Petersen, V.E. Koteliansky, and M.J. Bissell The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells J Clin Invest 95 2 1995 Feb 859 873
38. R. Kalluri, and M. Zeisberg Fibroblasts in cancer Nat Rev Cancer 6 5 2006 May 392 401
39. N.A. Bhowmick, E.G. Neilson, and H.L. Moses Stromal fibroblasts in cancer initiation and progression Nature 432 7015 2004 Nov 18 332 337 (Pubitemid 39551661)
40. M.M. Mueller, and N.E. Fusenig Friends or foes - bipolar effects of the tumour stroma in cancer Nat Rev Cancer 4 11 2004 Nov 839 849 (Pubitemid 39472951)
41. N.A. Bhowmick, A. Chytil, and D. Plieth TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia Science 303 5659 2004 Feb 6 848 851 (Pubitemid 38174665)
42. R. Hill, Y. Song, R.D. Cardiff, and T. Van Dyke Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis Cell 123 6 2005 Dec 16 1001 1011 (Pubitemid 41785416)